Abstract
It has been hypothesized that skin barrier function in early human life determines the onset of atopic dermatitis (AD) and atopic march. Finding early signs of skin abnormalities in newborns before the onset of AD may identify infants at risk to develop AD who can benefit from skin barrier enhancing therapies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
